Hoosier Cancer Research Network (HCRN) is committed to improving therapy for cancer patients through clinical research. Currently, less than 5% of cancer patients nationwide participate in clinical trials. These individuals allow researchers to conduct studies that will improve the lives of future generations of cancer patients.

HCRN clinical trials are offered through our network of more than 450 academic and community clinical sites throughout the United States. More than 250 thought leaders in multiple therapeutic areas provide expert scientific feedback through HCRN’s Clinical Trial Working Groups. 

For more information about Hoosier Cancer Research Network clinical trials, please see Current Trials.